Yatai Group announced that the company's 8th interim board of directors in 2026 reviewed and passed a number of proposals, including: adding new daily related transactions; continuing to apply for a credit limit of no more than 1,087 billion yuan at the Changchun branch of China Everbright Bank for a period of 1 year; providing guarantees for the financing of affiliated subsidiaries, with a cumulative guarantee amount of 14.952 billion yuan, accounting for 2,415.54% of the company's net assets audited to the parent company on December 31, 2025; shareholders of the holding subsidiary Jilin University Pharmacy plan to invest 2 million yuan to establish a wholly-owned subsidiary; and holding the sixth interim meeting in 2026. The above guarantees and related transactions still need to be submitted to the shareholders' meeting for consideration.

Yatai Group announced that the company's 8th interim board of directors in 2026 reviewed and passed a number of proposals, including: adding new daily related transactions; continuing to apply for a credit limit of no more than 1,087 billion yuan at the Changchun branch of China Everbright Bank for a period of 1 year; providing guarantees for the financing of affiliated subsidiaries, with a cumulative guarantee amount of 14.952 billion yuan, accounting for 2,415.54% of the company's net assets audited to the parent company on December 31, 2025; shareholders of the holding subsidiary Jilin University Pharmacy plan to invest 2 million yuan to establish a wholly-owned subsidiary; and holding the sixth interim meeting in 2026. The above guarantees and related transactions still need to be submitted to the shareholders' meeting for consideration.